tokens: Treatment of EDS secondary to central disorders of hypersomnolence is primarily pharmacologic with wakefulness - promoting agents such as modafinil , stimulants such as methylphenidate and amphetamines , and newer agents specifically designed to improve wakefulness ; behavioral interventions can provide a useful adjunct to pharmacologic treatment .